Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods

doi:10.1016/j.cjche.2021.06.013

中国化学工程学报 ›› 2022, Vol. 44 ›› Issue (4): 1-7.DOI: 10.1016/j.cjche.2021.06.013

• • 下一篇

Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods

Yang Gui¹, Kai Cheng², Ruojiao Wang¹, Sirui Liu¹, Chenyang Zhao¹, Rui Zhang¹, Ming Wang¹, Zhen Cheng², Meng Yang^1,2

1 Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;
2 Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, School of Medicine, Stanford University, Stanford CA 94305-5484, USA

收稿日期:2021-02-07 修回日期:2021-06-03 出版日期:2022-04-28 发布日期:2022-06-18
通讯作者: Zhen Cheng,E-mail:zcheng@stanford.edu;Meng Yang,E-mail:amengameng@hotmail.com
基金资助:
This work was supported by the National Natural Science Foundation of China (81421004, 81301268); Beijing Nova Program Interdisciplinary Cooperation Project xxjc201812); International S&T Cooperation Program of China (2015DFA30440); Beijing Nova Program (Z131107000413063); CAMS Innovation Fund for Medical Sciences (CIFMS 2020-I2M-C&T-B-035).

Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods

Yang Gui¹, Kai Cheng², Ruojiao Wang¹, Sirui Liu¹, Chenyang Zhao¹, Rui Zhang¹, Ming Wang¹, Zhen Cheng², Meng Yang^1,2

1 Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;
2 Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, School of Medicine, Stanford University, Stanford CA 94305-5484, USA

Received:2021-02-07 Revised:2021-06-03 Online:2022-04-28 Published:2022-06-18
Contact: Zhen Cheng,E-mail:zcheng@stanford.edu;Meng Yang,E-mail:amengameng@hotmail.com
Supported by:
This work was supported by the National Natural Science Foundation of China (81421004, 81301268); Beijing Nova Program Interdisciplinary Cooperation Project xxjc201812); International S&T Cooperation Program of China (2015DFA30440); Beijing Nova Program (Z131107000413063); CAMS Innovation Fund for Medical Sciences (CIFMS 2020-I2M-C&T-B-035).

摘要/Abstract

摘要： Follicular thyroid carcinoma (FTC) is the second most common form of thyroid malignancy, and it is associated with more aggressive growth and worse long-term survival outcomes relative to papillary thyroid carcinoma (PTC). Reliable approaches to preoperative FTC detection, however, remain to be established. Herein, a targeted Affibody-Au-Tripod nanoprobe was developed and successfully utilized to facilitate the targeted photoacoustic imaging (PAI) of epidermal growth factor receptor (EGFR)-positive cells and tumors. These Affibody-Au-Tripods were found to be highly sensitive and specific for cells expressing EGFR when used as a PA contrast agent in vitro, and studies conducted in an FTC-133 subcutaneous tumor model system in mice further revealed that these Affibody-Au-Tripods were able to specifically target these EGFR-expressing tumors while providing a strong photoacoustic signal in vivo. Importantly, these nanoprobes exhibited negligible cytotoxicity and robust chemical and physical stability, making Affibody-Au-Tripods promising candidates for targeted PAI-based FTC diagnosis. In addition, these nanoprobes have the potential to facilitate the individualized treatment of patients harboring EGFR-positive tumors.

关键词: Affibody, Follicular thyroid carcinoma, Nano-Au-Tripods, Nanoprobe, Photoacoustic imaging

Abstract: Follicular thyroid carcinoma (FTC) is the second most common form of thyroid malignancy, and it is associated with more aggressive growth and worse long-term survival outcomes relative to papillary thyroid carcinoma (PTC). Reliable approaches to preoperative FTC detection, however, remain to be established. Herein, a targeted Affibody-Au-Tripod nanoprobe was developed and successfully utilized to facilitate the targeted photoacoustic imaging (PAI) of epidermal growth factor receptor (EGFR)-positive cells and tumors. These Affibody-Au-Tripods were found to be highly sensitive and specific for cells expressing EGFR when used as a PA contrast agent in vitro, and studies conducted in an FTC-133 subcutaneous tumor model system in mice further revealed that these Affibody-Au-Tripods were able to specifically target these EGFR-expressing tumors while providing a strong photoacoustic signal in vivo. Importantly, these nanoprobes exhibited negligible cytotoxicity and robust chemical and physical stability, making Affibody-Au-Tripods promising candidates for targeted PAI-based FTC diagnosis. In addition, these nanoprobes have the potential to facilitate the individualized treatment of patients harboring EGFR-positive tumors.

Key words: Affibody, Follicular thyroid carcinoma, Nano-Au-Tripods, Nanoprobe, Photoacoustic imaging

Yang Gui, Kai Cheng, Ruojiao Wang, Sirui Liu, Chenyang Zhao, Rui Zhang, Ming Wang, Zhen Cheng, Meng Yang. Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods[J]. 中国化学工程学报, 2022, 44(4): 1-7.

参考文献

[1] Parameswaran R, Shulin Hu J, Min En N, Tan WB, Yuan NK, Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation, Ann R Coll Surg Engl 99 (2) (2017) 151-154
[2] S.A. Hundahl, I.D. Fleming, A.M. Fremgen, H.R. Menck, A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the US, 1985-1995[see commetns, Cancer 83 (12) (1998) 2638-2648
[3] N.A. Cipriani, S. Nagar, S.P. Kaplan, M.G. White, T. Antic, P.M. Sadow, B. Aschebrook-Kilfoy, P. Angelos, E.L. Kaplan, R.H. Grogan, Follicular thyroid carcinoma:How have histologic diagnoses changed in the last half-century and what are the prognostic implications?Thyroid 25 (11) (2015) 1209-1216
[4] Z.W. Baloch, V.A. Livolsi, Follicular-patterned lesions of the thyroid:The bane of the pathologist, Am J Clin Pathol 117 (1) (2002) 143-150
[5] F. Pacini, M. Schlumberger, H. Dralle, R. Ilisea, Y. Smith, V. Viersinga, European consensus on the management of patients with differentiated carcinoma of the thyroid from follicular epithelium, Vestn Khir Im I I Grek 167 (1) (2008) 52-56
[6] S. Suster, Thyroid tumors with a follicular growth pattern:Problems in differential diagnosis, Arch. Pathol. Lab. Med. 130 (7) (2006) 984-988
[7] C.M. Intenzo, H.Q. Dam, T.A. Manzone, S.M. Kim, Imaging of the thyroid in benign and malignant disease, Semin Nucl Med 42 (1) (2012) 49-61
[8] B.J. Vazquez, M.L. Richards, Imaging of the thyroid and parathyroid glands, Surg. Clin. N Am 91 (1) (2011) 15-32
[9] T.F. Heston, R.L. Wahl, Molecular imaging in thyroid cancer, Cancer Imaging 10 (2010) 1-7
[10] A. Gschwind, O.M. Fischer, A. Ullrich, The discovery of receptor tyrosine kinases:Targets for cancer therapy, Nat Rev Cancer 4 (5) (2004) 361-370
[11] L. Zhao, X.Y. Zhu, R. Jiang, M. Xu, N. Wang, G.G. Chen, Z.M. Liu, Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma, Int J Clin Exp Pathol 8 (9) (2015) 11236-11247
[12] M. Yang, L.Y. Zhao, X.J. He, N. Su, C.Y. Zhao, H.W. Tang, T. Hong, W.B. Li, F. Yang, L. Lin, B. Zhang, R. Zhang, Y.X. Jiang, C.H. Li, Photoacoustic/ultrasound dual imaging of human thyroid cancers:An initial clinical study, Biomed Opt Express 8 (7) (2017) 3449-3457
[13] E.I. Neuschler, R. Butler, C.A. Young, L.D. Barke, M.L. Bertrand, M. Böhm-Vélez, S. Destounis, P. Donlan, S.R. Grobmyer, J. Katzen, K.A. Kist, P.T. Lavin, E.V. Makariou, T.M. Parris, K.J. Schilling, F.L. Tucker, B.E. Dogan, A pivotal study of optoacoustic imaging to diagnose benign and malignant breast masses:A new evaluation tool for radiologists, Radiology 287 (2) (2018) 398-412
[14] Tummers WS, Miller SE, Teraphongphom NT, Gomez A, Steinberg I, Huland DM, Hong S, Kothapalli SR, Hasan A, Ertsey R, Bonsing BA, Vahrmeijer AL, Swijnenburg RJ, Longacre TA, Fisher GA, Gambhir SS, Poultsides GA, Rosenthal EL, Intraoperative pancreatic cancer detection using tumor-specific multimodality molecular imaging, Ann Surg Oncol 25 (7) (2018) 1880-1888
[15] I. Stoffels, S. Morscher, I. Helfrich, U. Hillen, J. Leyh, J. Lehy, N.C. Burton, T.C. Sardella, J. Claussen, T.D. Poeppel, H.S. Bachmann, A. Roesch, K. Griewank, D. Schadendorf, M. Gunzer, J. Klode, Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging, Sci Transl Med 7 (317) (2015) 317ra199
[16] Q.R. Fu, R. Zhu, J.B. Song, H.H. Yang, X.Y. Chen, Photoacoustic imaging:Contrast agents and their biomedical applications, Adv Mater 31 (6) (2019) e1805875. DOI:10.1002/adma.201805875
[17] J. Weber, P.C. Beard, S.E. Bohndiek, Contrast agents for molecular photoacoustic imaging, Nat Methods 13 (8) (2016) 639-650
[18] Reinhardt CJ, Chan J, Development of photoacoustic probes for in vivo molecular imaging, Biochemistry 57 (2) (2018) 194-199
[19] I. Steinberg, D.M. Huland, O. Vermesh, H.E. Frostig, W.S. Tummers, S.S. Gambhir, Photoacoustic clinical imaging, Photoacoustics, 14 (2019) 77-98
[20] K. Cheng, S.R. Kothapalli, H.G. Liu, A.L. Koh, J.V. Jokerst, H. Jiang, M. Yang, J.B. Li, J. Levi, J.C. Wu, S.S. Gambhir, Z. Cheng, Construction and validation of nano gold tripods for molecular imaging of living subjects, J Am Chem Soc 136 (9) (2014) 3560-3571
[21] Miao Z, Ren G, Liu H, Qi S, Wu S, Cheng Z, PET of EGFR expression with an 18F-labeled affibody molecule, J Nucl Med 53 (7) (2012) 1110-1118
[22] Yang M, Cheng K, Qi S, Liu H, Jiang Y, Jiang H, Li J, Chen K, Zhang H, Cheng Z, Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging, Biomaterials 34 (11) (2013) 2796-2806
[23] X.H. Su, K. Cheng, J. Jeon, B. Shen, G.T. Venturin, X. Hu, J.H. Rao, F.T. Chin, H. Wu, Z. Cheng, Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors, Mol Pharm 11 (11) (2014) 3947-3956
[24] K. Cheng, H. Chen, C.H. Jenkins, G.L. Zhang, W. Zhao, Z. Zhang, F. Han, J. Fung, M. Yang, Y.X. Jiang, L. Xing, Z. Cheng, Synthesis, characterization, and biomedical applications of a targeted dual-modal near-infrared-II fluorescence and photoacoustic imaging nanoprobe, ACS Nano 11 (12) (2017) 12276-12291
[25] M. Ferrari, Cancer nanotechnology:Opportunities and challenges, Nat Rev Cancer 5 (3) (2005) 161-171
[26] Weissleder R, Molecular imaging in cancer, Science 312 (5777) (2006) 1168-1171
[27] K.S. Valluru, K.E. Wilson, J.K. Willmann, Photoacoustic imaging in oncology:Translational preclinical and early clinical experience, Radiology 280 (2) (2016) 332-349
[28] L.V. Wang, S. Hu, Photoacoustic tomography:In vivo imaging from organelles to organs, Science 335 (6075) (2012) 1458-1462
[29] P.K. Upputuri, M. Pramanik, Recent advances toward preclinical and clinical translation of photoacoustic tomography:A review, J Biomed Opt 22 (4) (2017) 41006
[30] Valluru KS, Willmann JK, Willmann JK, Clinical photoacoustic imaging of cancer, Ultrasonography 35 (4) (2016) 267-280
[31] W.W. Li, X.Y. Chen, Gold nanoparticles for photoacoustic imaging, Nanomed. Lond. Engl. 10 (2) (2015) 299-320
[32] Yang X, Stein EW, Ashkenazi S, Wang LV, Nanoparticles for photoacoustic imaging, Wiley Interdiscip Rev Nanomed Nanobiotechnol 1 (4) (2009) 360-368
[33] Z. Cheng, O.P. de Jesus, D.J. Kramer, A. De, J.M. Webster, O. Gheysens, J. Levi, M. Namavari, S. Wang, J.M. Park, R. Zhang, H.G. Liu, B. Lee, F.A. Syud, S.S. Gambhir, 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors, Mol Imaging Biol 12 (3) (2010) 316-324
[34] J.H. Gao, K. Chen, Z. Miao, G. Ren, X.Y. Chen, S.S. Gambhir, Z. Cheng, Affibody-based nanoprobes for HER2-expressing cell and tumor imaging, Biomaterials 32 (8) (2011) 2141-2148
[35] S. Hoppmann, Z. Miao, S.L. Liu, H.G. Liu, G. Ren, A.D. Bao, Z. Cheng, Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting, Bioconjug Chem 22 (3) (2011) 413-421
[36] S.B. Qi, Z. Miao, H.G. Liu, Y.D. Xu, Y.Q. Feng, Z. Cheng, Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors, Bioconjug Chem 23 (6) (2012) 1149-1156

Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods

Photoacoustic detection of follicular thyroid carcinoma using targeted Nano-Au-Tripods

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价